Author:
VIGNAN NARLAPATI,TIWARI VIKALP,KHARAT AVINA,KUMARI RUCHI
Abstract
This study aims to reduce the inappropriate prescriptions of antifungal medications for vulvovaginitis candidiasis in a tertiary care hospital in central India. An ambispective, observational study was conducted in the Department of Pharmacology of MGM Medical College and Maharaja Yashwantrao Hospital in Indore, MP, over three months (i.e.,12 w from August to October 2023). The study encompassed a retrospective analysis of prescriptions for vaginal candidiasis over a period of five weeks in August-September 2023, followed by a prospective analysis over the subsequent five weeks of September-October 2023post-implementation of interactive training sessions, discussions, and antifungal guidelines for two weeks. From a total of 130 randomly selected prescriptions, 69 prescriptions were perused retrospectively, while 61 prescriptions received prospective analysis. The post-implemented audit showed a marked reduction in antifungal prescriptions with a difference of 12.4%. An increase in the documentation of examination findings was also observed, from 46.7% to 69.7%. This implementation successfully mitigated inappropriate prescriptions of antifungals, with sustained reductions demonstrated over the 3 mo of the study period, emphasizing the effectiveness of educational interventions.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference22 articles.
1. Sathi FA, Alam MM, Paul SK, Nasrin SA, Ahmed S, Haque N. Species identification and antifungal susceptibility pattern of candida isolates in patients with vulvovaginitis from Mymensingh, Bangladesh. Mymensingh Med J. 2023 Jul;32(3):638-43. PMID 37391952.
2. Mohammed BL, Bander KI, Hamad TA. Prevalence of vaginal candidiasis among women and diagnosis of Candida species from vaginal infection in Kirkuk city. Magallat Tikrit. 2023;20(4):5-15. doi: 10.25130/tjps.v20i4.1206.
3. Bairagi GR, Patel VP. Formulation and development of curcumin based emulgel in treatment and recurrence of vaginal candidiasis. Int J Curr Pharm Res. 2021;13(5):89-99. doi: 10.22159/ijcpr.2021v13i5.1900.
4. Learn more about vaginal candidiasis (vaginal yeast infections). Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/fungal/diseases/candidiasis/genital/index.html. [Last accessed on 02 Mar 2024]
5. Denning DW, Kneale M, Sobel JD, Rautemaa Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018 Nov;18(11):e339-47. doi: 10.1016/S1473-3099(18)30103-8, PMID 30078662.